Dark

ALNY
Alnylam Pharmaceuticals, Inc.
stock NASDAQ

At Close

May 30, 2025 3:59:59 PM EDT

304.47USD+3.950%(+11.57)3,116,163

0.00Bid 0.00Ask 0.00Spread

Pre-market

0.00USD-100.000%(-292.90)0

After-hours

May 30, 2025 4:24:30 PM EDT

304.56USD+0.029%(+0.09)208,226

OverviewOptionsHistoricalExchangesShortsMore

open chart

Market Cap

39.72B

CEO

John Maraganore

Headquarters

Cambridge, Massachusetts, USA

Industry

Biotechnology

Next Earnings

Jul 30, 2025 (59d)

REGN MDCO NVS SNY TEVA SRPT IONS ARWR OPK XLV

ALNY Stats

Avg. Vol. 10 Day

1,077,769

Avg. Vol. 30 Day

994,765

Employees

749

Market Cap

39,715,000,624

Shares Out.

130,388,393

On/Off Exchange

54%/46%

6 Month Beta

1.02

1 Year Beta

0.88

2 Year Beta

0.82

3 Year Beta

0.41

52 Week Low

147.25

52 Week High

306.00

SMA50

262.69

SMA200

261.68

1 Week

+5.00%

1 Month

+19.39%

3 Month

+23.44%

6 Month

+20.39%

1 Year

+105.21%

2 Year

+61.44%

5 Year

+128.04%

Profile

alnylam is developing an entirely new class of innovative medicines based on a breakthrough discovery in biology known as rna interference, or rnai. with rnai technology, we have the opportunity to treat disease and impact the lives of patients in a fundamentally new way by silencing disease-causing genes upstream of today's medicines.

ALNY Stock Summary

Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) stock price today is $304.47, and today's volume is 3,116,163. ALNY is up 3.950% today. The 30 day average volume is 994,765. ALNY market cap is 39.72B with 130,388,393 shares outstanding.